33rd Annual Congress of the European Association of Urology in 2018: Review of oncological topics

af A. S. Markova
Udgivet 2018-06-01

CURRENT POSSIBILITIES OF DRUG THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER

af A. S. Markova
Udgivet 2013-06-01

CURRENT POSSIBILITIES OF DRUG THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER

af A. S. Markova
Udgivet 2014-07-01

Government programs as a tool of budget planning and forecasting

af A A Markova
Udgivet 2013-12-01

Renal cell carcinoma: What’s new in 2018

af V. B. Matveev, A. S. Markova
Udgivet 2018-12-01

Efficacy and safety of radium-223 in routine clinical practice

af V. B. Matveev, A. S. Markova
Udgivet 2020-12-01

Radium-223 in treatment of castration-resistant prostate cancer with skeletal metastases

af V. B. Matveev, A. S. Markova
Udgivet 2017-09-01

Possibilities of optimization of the second line targeted therapy for metastatic renal cell carcinoma

af A. S. Markova, V. B. Matveev
Udgivet 2017-09-01

ANDROGEN DEPRIVATION THERAPY WITH LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONISTS FOR PROSTATE CANCER: BEST DISEASE CONTROL WITH A LOWER RISK OF SIDE EFFECTS. RESULTS OF ANALYSI...

af A. S. Markova, V. B. Matveev
Udgivet 2014-03-01

Noninterventional studies of depot formulations of LHRH analogues for prostate cancer in routine clinical practice. The launch of an observational program to assess the use of Elig...

af V. B. Matveev, A. S. Markova
Udgivet 2015-03-01

Final results of the prospective multicenter observational program RU-EGD-NI-001 for evaluation of efficacy and tolerability of the 6-month depot Eligard 45 mg in patients with adv...

af V. B. Matveev, A. S. Markova
Udgivet 2017-06-01

Intermediate results of the observational program on the Eligard (45 mg) administration in the clinical practice

af V. B. Matveev, A. S. Markova
Udgivet 2016-06-01

MIDDLE PLEISTOCENE SMALL MAMMAL fAUNAS Of EUROPE: EVOLUTION, BIOSTRATIGRAPHY, CORRELATIONS

af A. K. Markova, A. Yu. Puzachenko
Udgivet 2018-09-01

PROGRESSING CHRONIC KIDNEY DISEASE AND THE 12-MONTH DYNAMICS OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS

af A. V. Markova, Yu. G. Schwartz
Udgivet 2013-10-01

Tactics of Reporting Bad News in Professional Communication between a Doctor and a Patient

af A. A. Markova, M. I. Barsukova
Udgivet 2022-03-01

CONCEPTION AND REAL ATTITUDE TO SCHOOLCHILDREN’S HEALTH IN MOSCOW: RESULTS OF SOCIOLOGICAL STUDY

af A.I. Markova, A.V. Lyakhovich
Udgivet 2010-11-01

SEQUENTIAL THERAPY OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: NEW POSSIBILITIES

af A. S. Markova, V. B. Matveev, B. M. Nazranov
Udgivet 2018-09-01

TESTICULAR CAPILLARY HEMANGIOMA: DESCRIPTION OF A CASE

af A. S. Markova, L. L. Gurariy, V. D. Ermilova
Udgivet 2012-03-01

Safety of enzalutamide in patients with progressive castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy: a phase II, multicenter, single-arm,...

af B. Ya. Alekseev, V. B. Matveev, A. Chkhotua, A. S. Markova
Udgivet 2018-03-01

Luteinizing hormone-releasing hormone agonists for prostate cancer patients: routine clinical practice of Russian cancer urologists

af V. B. Matveev, B. Ya. Alekseev, B. Sh. Kamolov, A. S. Markova
Udgivet 2021-07-01